A detailed history of Stephens Inc transactions in Danaher Corp stock. As of the latest transaction made, Stephens Inc holds 13,992 shares of DHR stock, worth $3.29 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
13,992
Previous 13,953 0.28%
Holding current value
$3.29 Million
Previous $3.49 Million 11.56%
% of portfolio
0.06%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$239.25 - $280.76 $9,330 - $10,949
39 Added 0.28%
13,992 $3.89 Million
Q2 2024

Aug 06, 2024

BUY
$235.51 - $267.98 $123,642 - $140,689
525 Added 3.91%
13,953 $3.49 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $38,852 - $44,320
-173 Reduced 1.27%
13,428 $3.35 Million
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $25,728 - $32,405
139 Added 1.03%
13,601 $3.15 Million
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $269,673 - $307,287
-1,157 Reduced 7.91%
13,462 $3.34 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $1.69 Million - $1.93 Million
-7,530 Reduced 34.0%
14,619 $3.51 Million
Q1 2023

May 15, 2023

SELL
$239.75 - $277.0 $278,349 - $321,597
-1,161 Reduced 4.98%
22,149 $5.58 Million
Q4 2022

Jan 25, 2023

BUY
$241.42 - $282.29 $1.21 Million - $1.41 Million
4,996 Added 27.28%
23,310 $6.19 Million
Q3 2022

Nov 02, 2022

SELL
$247.06 - $1507.4 $45,953 - $280,376
-186 Reduced 1.01%
18,314 $4.73 Million
Q2 2022

Aug 03, 2022

BUY
$237.11 - $299.66 $30,112 - $38,056
127 Added 0.69%
18,500 $4.69 Million
Q1 2022

May 04, 2022

SELL
$257.27 - $315.76 $388,734 - $477,113
-1,511 Reduced 7.6%
18,373 $5.39 Million
Q4 2021

Mar 07, 2022

SELL
$292.08 - $329.01 $36,217 - $40,797
-124 Reduced 0.62%
19,884 $6.54 Million
Q3 2021

Oct 27, 2021

SELL
$272.21 - $332.43 $164,959 - $201,452
-606 Reduced 2.94%
20,008 $6.09 Million
Q2 2021

Aug 12, 2021

SELL
$225.08 - $271.69 $146,527 - $176,870
-651 Reduced 3.06%
20,614 $5.53 Million
Q1 2021

May 14, 2021

SELL
$212.38 - $245.9 $1.88 Million - $2.18 Million
-8,847 Reduced 29.38%
21,265 $4.79 Million
Q4 2020

Feb 10, 2021

BUY
$212.5 - $245.46 $1.23 Million - $1.42 Million
5,782 Added 23.76%
30,112 $6.69 Million
Q3 2020

Nov 13, 2020

SELL
$177.16 - $215.33 $105,764 - $128,552
-597 Reduced 2.39%
24,330 $5.24 Million
Q2 2020

Aug 24, 2020

BUY
$128.7 - $176.83 $401,801 - $552,063
3,122 Added 14.32%
24,927 $4.41 Million
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $2.1 Million - $2.92 Million
-17,259 Reduced 44.18%
21,805 $3.02 Million
Q4 2019

Feb 14, 2020

SELL
$133.47 - $153.48 $173,511 - $199,524
-1,300 Reduced 3.22%
39,064 $6 Million
Q3 2019

Oct 18, 2019

SELL
$135.4 - $146.47 $820,388 - $887,461
-6,059 Reduced 13.05%
40,364 $5.83 Million
Q2 2019

Aug 01, 2019

BUY
$124.88 - $143.73 $60,317 - $69,421
483 Added 1.05%
46,423 $6.64 Million
Q1 2019

May 03, 2019

SELL
$97.62 - $132.29 $310,333 - $420,549
-3,179 Reduced 6.47%
45,940 $6.07 Million
Q4 2018

Feb 11, 2019

SELL
$94.85 - $109.54 $188,751 - $217,984
-1,990 Reduced 3.89%
49,119 $5.07 Million
Q3 2018

Nov 14, 2018

SELL
$98.13 - $108.9 $1.57 Million - $1.74 Million
-15,980 Reduced 23.82%
51,109 $5.55 Million
Q2 2018

Aug 10, 2018

BUY
$96.1 - $103.24 $372,291 - $399,951
3,874 Added 6.13%
67,089 $6.62 Million
Q1 2018

May 03, 2018

SELL
$92.16 - $103.8 $650,465 - $732,620
-7,058 Reduced 10.04%
63,215 $6.19 Million
Q4 2017

Feb 05, 2018

SELL
$85.26 - $94.62 $131,385 - $145,809
-1,541 Reduced 2.15%
70,273 $6.52 Million
Q3 2017

Nov 08, 2017

SELL
$79.29 - $88.45 $30,288 - $33,787
-382 Reduced 0.53%
71,814 $6.16 Million
Q2 2017

Aug 10, 2017

BUY
N/A
72,196
72,196 $6.09 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Stephens Inc Portfolio

Follow Stephens Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.